Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches. (2017)

First Author: Mariot V
Attributed to:  MICA: MRC Centre for Neuromuscular Diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-017-01486-4

PubMed Identifier: 29192144

Publication URI: http://europepmc.org/abstract/MED/29192144

Type: Journal Article/Review

Volume: 8

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723